We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
RAPP
101
Rapport Therapeutics
RAPP
$2.05B
$2.05B $42.68 3%
URGN icon
102
UroGen Pharma
URGN
$2.04B
$2.04B $41.74 2.11%
NUVB icon
103
Nuvation Bio
NUVB
$2.04B
$2.04B $5.80 2.36%
VCEL icon
104
Vericel Corp
VCEL
$2.03B
$2.03B $39.72 0.3%
AGIO icon
105
Agios Pharmaceuticals
AGIO
$1.96B
$1.96B $32.81 1.23%
ADMA icon
106
ADMA Biologics
ADMA
$1.93B
$1.93B $8.61 5.8%
MESO
107
Mesoblast
MESO
$1.91B
$1.91B $14.74 1.86%
GHRS icon
108
GH Research
GHRS
$1.89B
$1.89B $27.55 1.22%
FTRE icon
109
Fortrea Holdings
FTRE
$1.88B
$1.88B $19.73 13.3%
COAG
110
Hemab Therapeutics
COAG
$1.87B
$1.87B $40.11 0.89%
BHVN icon
111
Biohaven
BHVN
$1.86B
$1.86B $12.34 2.37%
ZYME icon
112
Zymeworks
ZYME
$1.86B
$1.86B $26.05 2.98%
LKFT
113
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$1.83B $27.92 4.53%
STOK icon
114
Stoke Therapeutics
STOK
$1.82B
$1.82B $28.15 4.9%
SEPN
115
Septerna Inc
SEPN
$1.81B
$1.81B $38.86 1.74%
NBTX
116
Nanobiotix
NBTX
$1.79B
$1.79B $35.26 1.32%
VIR icon
117
Vir Biotechnology
VIR
$1.77B
$1.77B $10.44 3.06%
XNCR icon
118
Xencor
XNCR
$1.77B
$1.77B $23.75 3.18%
KLRA
119
Kailera Therapeutics
KLRA
$1.74B
$1.74B $13.45 2.18%
RXRX icon
120
Recursion Pharmaceuticals
RXRX
$1.74B
$1.74B $3.24 4.99%
KARD
121
Kardigan Inc
KARD
$1.74B
$1.74B $18.56 2.57%
TSHA icon
122
Taysha Gene Therapies
TSHA
$1.65B
$1.65B $5.06 1%
IMCR icon
123
Immunocore
IMCR
$1.64B
$1.64B $31.77 2.13%
ANAB icon
124
AnaptysBio
ANAB
$1.62B
$1.62B $54.68 1.05%
SNDX icon
125
Syndax Pharmaceuticals
SNDX
$1.62B
$1.62B $18.09 1.42%
3 4
5
6 7

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 565 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.28T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.3B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.